Table 5.
Study | Duration (Days) | Group | Bone formation markers | Bone resorption markers | Other key markers | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NTX | DPD | PYD | BSAP | Total ALP | OCN | Urine Calcium | Serum Calcium | PTH | 1,25(OH)2 Vit D | 25(OH) Vit D | Creatinine | |||
Shackelford5 | 119 days | CON | ↑* | ↑* | ↑* | ↓ | ↑ | ↑ | x | ↑ | ↓ | ↓* | ↑ | x |
RVE | ↑* | ↑* | ↑* | ↑*^ | ↑*^ | ↑*^ | x | ↓* | ↓ | ↑^ | ↑ | x | ||
Rittweger30 | 90 days | CON | x | ↑* | ↑* | x | ↑** | x | x | = | = | x | x | x |
FW | x | ↑* | ↑* | x | ↑** | x | x | = | = | x | x | x | ||
Smith32 | 60 days | CON | ↑ | = | x | ↑ | ↑ | = | = | ↑ | ↓ | ↓ | ↓* | x |
LBNP TM + RE | ↑ | ↑ | x | ↑ | ↑*^ | ↑ | ↓ | ↓ | ↓ | ↓ | ↓* | x | ||
Zwart31 | 30 days | CON | ↑** | ↑** | ↑** | ↓ | ↓ | ↓ | ↑ | ↓** | ↓ | ↓ | ↓ | ↑* |
LBNP TM | ↑** | ↑** | ↑** | ↓ | ↓ | ↑ | ↓ | ↓** | ↓ | ↓ | = | ↑* | ||
Cavanagh28 | 84 Days | CON | ↑* | x | x | ↑ | x | x | ↑ | x | x | x | x | ↓ |
ZLS | ↑* | x | x | ↑ | x | x | ↓ | x | x | x | x | ↓ |
The biomarker changes from baseline to post-bed-rest. ↓ decrease in levels, ↑ increase in levels, X no data, = no change
NTX n-telopeptide, DPD deoxypyridinoline, PYD pyridinium cross-links, total ALP total alkaline phosphatase, BASP bone specific alkaline phosphatase, OCN osteocalcinin, PTH Parathyroid hormone, CON control group, RVE resistive vibration exercise, FW flywheel, LBNP TM lower body negative pressure treadmill, ZLS zero-gravity locomotion simulator
*Significant from baseline p < 0.05, **significant from baseline p < 0.01 (Cavanagh28 used a two sample t-test. Zwart31 and Smith32 used post hoc testing with the Bonferroni method. Rittweger30 and Shackelford5 used analysis of variance), ^significant between exercise and control groups p < 0.05 (Cavanagh28 used two sample t-test. All other studies used analysis of variance)